Support our Foundation of Myology project
REN001-201 / STRIDE
A double-blind, placebo-controlled study to evaluate the efficacy and safety of 24 weeks of treatment with REN001 in patients with primary mitochondrial myopathy.
Support our Foundation of Myology project
A double-blind, placebo-controlled study to evaluate the efficacy and safety of 24 weeks of treatment with REN001 in patients with primary mitochondrial myopathy.